The FDA is allowed to visit your company to perform an inspection. In the course of the visit they may bring some issue to your attention in the form of an observation (aka a 483). This article reviews what a 483 looks like, some of the more common issues flagged in medical device companies, and how to respond.
We invite you to download our paper on the topic of 483 Observations.
Vehicles are only becoming more software-defined. As innovations break into the industry, automotive engineers and Tier 1 suppliers must keep up. Explore how they do so in this eBook.What You Will Learn Discover how: Software has become the differentiator in...
Key Takeaways Visibility, not complexity, is often the real problem: Disconnected requirements, hardware, software, testing, and quality data make it difficult for teams to understand product status and downstream impacts. Data silos create delays and compliance risk:...
Key Takeaways AI agents need lifecycle context, not just code access: Without visibility into dependencies, pipelines, security scans, and production signals, agents are more likely to generate incorrect or incomplete changes. GitLab Orbit creates a live context graph...
Vehicles are only becoming more software-defined. As innovations break into the industry, automotive engineers and Tier 1 suppliers must keep up. Explore how they do so in this eBook.What You Will Learn Discover how: Software has become the differentiator in...